| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |